Boston Scientific Corporation (BSC) is a developer and manufacturer of medical devices.
The company was founded in 1979 by John Abele and Pete Nicholas as a holding company for Medi-Tech, a pioneer of interventional medicine.
The company’s founding principle was to bring lower-cost, lower-trauma, and more accessible medical options to patients.
Today BSC makes medical supplies and devices used to diagnose and treat conditions in the cardiovascular field, as well as electrophysiology, endoscopy, pain management, urology, and women’s health.
The company manufactures 13,000 products in 12 global manufacturing facilities.
BCS’s best known product is the Taxus Stent, a drug-eluting stent that opens clogged arteries.
Boston Scientific Corporation trades publicly on the New York Stock Exchange under the symbol BSX, is a member of the S&P 500, is #279 in the Fortune 500, has 23,000 employees, and had $7.16 billion in revenue in 2013.
Boston Scientific CorporationBoston Scientific Corporation (BSC) is a developer and manufacturer of medical devices.
The company was founded in 1979 by John Abele and Pete Nicholas as a holding company for Medi-Tech, a pioneer of interventional medicine.
The company’s founding principle was to bring lower-cost, lower-trauma, and more accessible medical options to patients.
History
Today BSC makes medical supplies and devices used to diagnose and treat conditions in the cardiovascular field, as well as electrophysiology, endoscopy, pain management, urology, and women’s health.
The company manufactures 13,000 products in 12 global manufacturing facilities.
BCS’s best known product is the Taxus Stent, a drug-eluting stent that opens clogged arteries.
Boston Scientific Corporation trades publicly on the New York Stock Exchange under the symbol BSX, is a member of the S&P 500, is #279 in the Fortune 500, has 23,000 employees, and had $7.16 billion in revenue in 2013.
